Profound differences in IgE and IgG recognition of micro‐arrayed allergens in hyper‐IgE syndromes
Open Access
Abstract
Background The specificities of IgE and IgG for allergen molecules in patients with inborn errors of immunity (IEI) have not been investigated in detail. Objective To study IgE and IgG antibody specificities in patients with defined hyper-IgE-syndromes (HIES) using a comprehensive panel of allergen molecules. Methods We used chips containing 174 micro-arrayed allergen molecules to analyze allergen-specific IgE and IgG levels in sera from two groups of HIES patients: Autosomal recessive mutations in phosphoglucomutase-3 (PGM3); Autosomal dominant negative mutations of STAT3 (STAT3); and age-matched subjects with allergic sensitizations. Assays with rat basophil leukemia cells transfected with human FcεRI were performed to study the biological relevance of IgE sensitizations. Results Median total IgE levels were significantly lower in the sensitized control group (212.9 kU/L) as compared to PGM3 (5042 kU/L) and STAT3 patients (2561kU/L). However, PGM3 patients had significantly higher allergen-specific IgE levels and were sensitized to a large number of allergen molecules as compared to STAT3 patients. Biological relevance of IgE sensitization was confirmed for PGM3 patients by basophil activation testing. PGM3 patients showed significantly lower cumulative allergen-specific IgG responses in particular to milk and egg allergens as compared to STAT3 patients and sensitized controls whereas total IgG levels were comparable to STAT3 patients and significantly higher than in controls. Conclusion The analysis with multiple microarrayed allergen molecules reveals profound differences of allergen-specific IgE and IgG recognition in PGM3 and STAT3 patients which may be useful for classification of disease and clinical characterization of patients.Keywords
This publication has 40 references indexed in Scilit:
- Proteomicsplusgenomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndromeClinical and Experimental Immunology, 2011
- Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responsesJournal of Allergy and Clinical Immunology, 2011
- A convenient and sensitive allergy test: IgE crosslinking‐induced luciferase expression in cultured mast cellsAllergy, 2010
- Primary immune deficiencies with aberrant IgE productionJournal of Allergy and Clinical Immunology, 2008
- Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndromeNature, 2007
- The cradle of IgE autoreactivity in atopic eczema lies in early infancyJournal of Allergy and Clinical Immunology, 2005
- Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatmentThe FASEB Journal, 2002
- Hyper-IgE Syndrome with Recurrent Infections — An Autosomal Dominant Multisystem DisorderNew England Journal of Medicine, 1999
- International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methodsEuropean Respiratory Journal, 1995
- JOB'S SYNDROMEThe Lancet, 1966